![AN2 Therapeutics Inc](/common/images/company/N_ANTX.png)
AN2 Therapeutics Inc (ANTX)
NASDAQ
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -85.915 | -50.961 | -53.652 |
Return on Equity (%) | 118.361 | -178.378 | -58.828 |
Return on Invested Capital (%) | -76.235 | -57.06 | -74.12 |
Operating Margin (%) | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A |
Book Value Per Share | 0.01 | 4.915 | 4.193 |
Earnings Per Share | -0.005 | -2.205 | -2.177 |
Cash Per Share | 0.002 | 1.403 | 0.526 |
Working Capital Per Share | 0.009 | 4.712 | 3.243 |
Operating Profit Per Share | N/A | N/A | N/A |
EBIT Per Share | -0.004 | -2.111 | -2.177 |
EBITDA Per Share | -0.004 | -2.111 | -2.177 |
Free Cash Flow Per Share | 0.008 | -2.205 | -2.177 |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
Current Ratio | 17.704 | 13.724 | 7.869 |
Quick Ratio | 17.247 | 13.368 | 7.64 |
Inventory Turnover (Days) | N/A | N/A | N/A |
Shares Outstanding | N/A | 19.4M | N/A |
Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | ||||||
Shares Outstanding | N/A | 19.4M | 19.4M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | 10.544 | N/A | N/A | N/A | 10.908 |
Quick Ratio | N/A | N/A | N/A | 10.333 | N/A | N/A | N/A | 10.711 |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 83.22M |
Price to Earnings Ratio | -1.32 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 5.45 |
Price to Book Ratio | 0.68 |
Dividend Yield | - |
Shares Outstanding | 29.83M |
Average Volume (1 week) | 129.19k |
Average Volume (1 Month) | 164.44k |
52 Week Change | -62.88% |
52 Week High | 22.22 |
52 Week Low | 1.91 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.